Al's Comment:

 If your tumor has the BRAF V600E mutation it may be worth looking at this combination.   Although only a small % of patients responded, they had a few complete responses that are lasting a long time!


Posted on: 05/08/2021

Dabrafenib-trametinib combination active in BRAF V600E-mutant glioma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!